Circulating Th17.1 cells as candidate for prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: exploratory research
S. Maeda, S. Osaga, T. Maeda, N. Takeda, S.-y. Tamechika, T. Naniwa, A. Niimi
This study identifies Th17.1 cells as a biomarker predicting response to abatacept in rheumatoid arthritis patients.
bioRxiv · Mar 29, 2019Immunology